🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchClinicalTrials.gov GLP-1 trial tracker — updated weekly Page 17

ClinicalTrials.gov GLP-1 trial tracker — updated weekly

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 411 replies 11,865 viewsPage 17 of 20
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Aug 1, 2025 at 6:21 AM#81

Closing the loop on my own question.

Update, and it is the boring outcome: nothing was wrong. The measurement I was reading had moved less than its own week-to-week variation, which somebody said upthread and I did not believe.

14 12Dr.EM_Chicago, pete_RVA, CarlaRPh_TPA and 11 others
Reply Quote Save Share Report
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
Aug 9, 2025 at 6:04 AM#82

Adding the numbers, since they settle part of this. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

Ask again with the specifics and you will get a better answer than this one.

Last edited: Aug 9, 2025 at 10:04 AM
15 13dave_SLC, FDA_TrackerJim, ricardo_MIA and 12 others
Reply Quote Save Share Report
newstart_MO
New Member
12
45
Feb 2026
Springfield, MO
Aug 17, 2025 at 5:42 AM#83

Following on from Dr.RenalNash — and this may be the naive question:

How long did you give it before you decided it was working?

16 14HPLC_Greg, LibrarianMeg, bri_stats and 13 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
MikeKY_noInsulin
Member
267
1,234
Oct 2024
Louisville, KY
Aug 25, 2025 at 5:15 AM#84
PeptideChemSF said:
If you are going to change something, change one thing and give it long enough to express itself.

I read this differently from PeptideChemSF, on substance rather than tone. The objection nobody has made: this only works if the measurement is doing what we assume it is doing, and that assumption has not been tested here.

Correct me if the detail matters more than I have assumed.

17 15amy_econ_NJ, bbq_ray_KC, oliver_london and 14 others
Reply Quote Save Share Report
maria_elpaso
Member
312
1,456
Sep 2024
El Paso, TX
Sep 2, 2025 at 4:44 AM#85
PeptideChemSF said:
If you are going to change something, change one thing and give it long enough to express itself.

Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.

Last edited: Sep 2, 2025 at 10:44 AM
18 16LibrarianMeg, bri_stats, pete_manc_UK and 15 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register